One of the primary scientific aims of the Open Insulin Foundation is to engineer a strain of microorganism that can produce sufficient quantities of insulin glargine for downstream purification and formulation. Toward this end, we took inspiration from a published protocol and came up with a strategy to engineer the budding yeast Pichia pastoris with the capacity to inducibly express glargine and secrete it into the extracellular growth media.